共 50 条
- [42] Fosfomycin-associated adverse events: A disproportionality analysis of the FDA Adverse Event Reporting System DRUG DISCOVERIES AND THERAPEUTICS, 2025,
- [43] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS) BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
- [46] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS) BMC Pharmacology and Toxicology, 24
- [47] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110